White label ELPA - ClinicalTrials.eu

Study of Galinpepimut-S compared to standard therapy for patients with acute myeloid leukemia who achieved complete remission after second-line treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia (in remission)
Investigated Drugs:
Study on Reducing Antibiotic Use in Severe COPD Exacerbation with Amoxicillin, Cefotaxime, and Ciprofloxacin for Patients on Mechanical Ventilation or Oxygen Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
Study on the Effectiveness of Human Hepatitis B Immunoglobulin for Patients with Chronic Hepatitis B

Not recruiting

2 1 1 1
Investigated Drugs:
- Human Hepatitis B Immunoglobulin
Study on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot

Not recruiting

3 1 1
Investigated Diseases:
- Neuropathic arthropathy
- Diabetes mellitus
Investigated Drugs:
- Denosumab
- Saline
Study on Atezolizumab and Cabozantinib for Patients with Advanced Renal Cell Carcinoma After Tumor Progression Post-Immune Checkpoint Inhibitor Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Renal cell carcinoma
Investigated Drugs:
- Cabozantinib
- Atezolizumab
Study on Anifrolumab for Patients with Primary Sjogren’s Syndrome

Not recruiting

2 1 1
Investigated Diseases:
- Sjogren’s syndrome
Investigated Drugs:
- Anifrolumab
Study on Thymalfasin for Adults with Cystic Fibrosis

Not recruiting

2 1 1 1
Investigated Diseases:
- Cystic fibrosis
Investigated Drugs:
- Thymalfasin
Study on Reducing Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Using Cisplatin for Patients with Squamous Cell Carcinoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Oropharyngeal squamous cell carcinoma
Investigated Drugs:
- Cisplatin
Study on the Safety and Effectiveness of Venetoclax, Atezolizumab, and Obinutuzumab for Patients with Richter Syndrome from Chronic Lymphocytic Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Richter’s syndrome
Investigated Drugs:
Study on Durvalumab, Olaparib, and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer in Spain

Not recruiting

3 1 1 1
Investigated Diseases:
- Endometrial cancer recurrent
Investigated Drugs:
- Durvalumab
- Olaparib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies